PSB-CB-27

Overview

PSB-CB-27 is a potent and selective GPR18 inhibitor with an IC 50 of 0.65 μM. PSB-CB-27 shows selectivity over Human GPR55 , Human CB1 receptor, and Human CB2 receptor. PSB-CB-27 leads to a complete blockade of Δ9-Tetrahydrocannabinol (THC)-induced GPR18 activation. PSB-CB-27 can be used for inflammatory diseases and cancer immunotherapy research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Orphan GPCR

Product Information

• Catalog No.: HY-159161
• CAS No.: 2237222-16-9
• Molecular Formula: C25H27ClN2O3S
• Molecular Weight: 471.01
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source